Back to Erste Asset Management GmbH Erste Asset Management GmbH

HALOHALO

Showing 8 of 30 quarters

Position history for Erste Asset Management GmbHErste Asset Management GmbH's holdings in Halozyme Therapeutics, Inc.

Yes. Erste Asset Management holds 34,800 shares of HALO (Halozyme Therapeutics), worth $2.7M, as of its Q2 2026 13F filing. It reduced the position by 76,500 shares (-68.7%) from Q1 2026. Erste Asset Management has held HALO in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$2.7M

Current Shares

34,800

Total Value Change

-$37,302

Total Shares Change

-13,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
34,800
-68.7%
$2.7M0.0%$78.27
0
2026-Q1
Increased
111,300
+219.8%
$6.9M0.1%$64.63
44
2025-Q4
Unchanged
34,800
0.0%
$2.4M0.0%$67.30
0
2025-Q3
Unchanged
34,800
0.0%
$2.6M0.0%$73.34
0
2025-Q2
Decreased
34,800
-27.2%
$1.8M0.0%$52.02
0
2025-Q1
Unchanged
47,800
0.0%
$3.1M0.0%$63.81
0
2024-Q4
Unchanged
47,800
0.0%
$2.3M0.0%$47.81
0
2024-Q3
Unchanged
47,800
0.0%
$2.7M0.0%$57.24
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used